In other countries
The same active substances on other registers, the same brand first.
- Mar-EthosuximideCanada · 250 MG · Capsule · Marcan Pharmaceuticals INCSame form
- Odan-EthosuximideCanada · 250 MG · Capsule · Odan LaboratoriesltdSame form
- ZarontinCanada · 250 MG · Capsule · Searchlight Pharma INCSame form
- ETOSUXIMIDA FAES 250 mg CAPSULAS DURASSpain · 250 mg · cápsula dura · Faes Farma S.A.Same form
- ZarontinItaly · Capsula molle · Essential Pharma (M) LTDSame form
- Ethosuximide Strides 250 mg zachte capsulesNetherlands · Capsule, zacht · Strides Pharma (Cyprus) LimitedSame form
- Ethymal 250 mg, capsules, zachtNetherlands · Capsule, zacht · Aurobindo Pharma B.V.Same form
- ZarontinNew Zealand · Cap 250 mgSame form
- PETINIMID 250 mgRomania · 250mg · caps. moi · Lannacher Heilmittel Ges.M.B.H.Same form
- Petinimid Caps MoiRomania · 250mg · caps. moi · Gerot Pharmazeutika GMBHSame form
- Zarontin Cap 250MGSaudi Arabia · Park-DavisSame form
- EthosuximideUnited States · 250MG · capsule · Puracap Pharm LLCSame form
- ZarontinUnited States · 250MG · capsule · Parke DavisSame form
- EtoxinBrazil · Apsen Farmaceutica S/ASame substance
- Etosuccimide GlenmarkItaly · Soluzione orale · Glenmark Arzneimittel GMBHSame substance
- ZarontinItaly · Sciroppo · Farmed S.R.L.Same substance
- Ethymal 250 mg/4 ml, siroopNetherlands · Stroop · Aurobindo Pharma B.V.Same substance
- ZarontinNew Zealand · Oral liq 250 mg per 5 mlSame substance
- ZarontinNew Zealand · Oral liq 50 mg per mlSame substance
- Suxinutin®Serbia · 250mg/5mL · sirup · Clinres Farmacija D.O.O. BeogradSame substance
- Zarontin Syr 250MG-5MLSaudi Arabia · Park-DavisSame substance
- EthosuximideUnited States · 250MG/5ML · syrup · Chartwell RXSame substance
Packs
| Pack | Code | Status |
|---|---|---|
| 28 kapsula u bočici, u kutiji | HR-H-851531210-01 | nije stavljeno u promet |
| 50 kapsula u bočici, u kutiji | HR-H-851531210-02 | nije stavljeno u promet |
| 56 kapsula u bočici, u kutiji | HR-H-851531210-03 | nije stavljeno u promet |
| 100 kapsula u bočici, u kutiji | HR-H-851531210-04 | stavljeno u promet |
| 112 kapsula u bočici, u kutiji | HR-H-851531210-05 | nije stavljeno u promet |
| 200 kapsula u bočici, u kutiji | HR-H-851531210-06 | nije stavljeno u promet |
| 50 kapsula u blisteru, u kutiji | HR-H-851531210-07 | nije stavljeno u promet |
| 100 kapsula u blisteru, u kutiji | HR-H-851531210-08 | nije stavljeno u promet |
| 200 kapsula u blisteru, u kutiji | HR-H-851531210-09 | nije stavljeno u promet |
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
HALMED — Agencija za lijekove i medicinske proizvode RH
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Ethosuximide
- Dosage form
- Kapsula, meka
- Register
- Croatia (HALMED)
- Status
- Marketed
- Status in the register
- stavljeno u promet; nema nestašice
- Authorised
- 26 May 2025
- Registration
- HR-H-851531210
- Marketing authorisation holder
- Makpharm d.o.o., Trnjanska cesta 37/1, Zagreb, Hrvatska
- Manufacturer
- Fairmed Healthcare GmbH, Lübeck, Njemačka
- ATC code
- N03AD01
- Group
- Nervous system
- Procedure
- National, MRP or DCP
- Supply
- na recept; u ljekarni